Yun Liao

Yun Liao

Auto-generated profile, based on publicly available information

Yun Liao

Department of Laboratory Medicine West China Hospital Sichuan University Chengdu Sichuan China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2024 in Nature
Verified
Journal Article
Closed access
PDF file
YLYun Liao
Yun Liao
IGIris H. Gao
Iris H. Gao
TKTakato Kusakabe
Takato Kusakabe
WLWoan-Yu Lin
Woan-Yu Lin
AGAlexander Grier
Alexander Grier
IIIliyan D. Iliev
Iliyan D. Iliev

7 April 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
XCXing Chen
Xing Chen
JZJunjie Zhao
Junjie Zhao
THTomasz Herjan
Tomasz Herjan
LHLingzi Hong
Lingzi Hong
YLYun Liao
Yun Liao
XLXiaoxia Li
Xiaoxia Li
Increasing evidence suggests that intratumoral inflammation has an outsized influence on antitumor immunity. Here, we report that IL-17, a proinflammatory cytokine widely associated with poor prognosis in solid tumors, drives the therapeutic failure of anti–PD-L1. By timing the deletion of IL-17 signaling specifically in cancer-associated fibroblasts (CAFs) in late-stage tumors, we show that IL-17 signaling drives immune exclusion by activating a collagen deposition program in murine models of cutaneous squamous cell carcinoma (cSCC). Ablation of IL-17 signaling in CAFs increased the infiltration of cytotoxic T cells into the tumor mass and sensitized otherwise resistant cSCC to anti–PD-L1 treatment. Mechanistically, the collagen deposition program in CAFs was driven by IL-17–induced translation of HIF1α, which was mediated by direct binding of Act1, the adaptor protein of IL-17 receptor, to a stem-loop structure in the 3′ untranslated region (UTR) in Hif1α mRNA. Disruption of Act1’s binding to Hif1α mRNA abolished IL-17–induced collagen deposition and enhanced anti–PD-L1–mediated tumor regression.

14 November 2022 in The EMBO Journal
Verified
Journal Article
Open access
YLYun Liao
Yun Liao
XCXing Chen
Xing Chen
WMWilliam Miller‐Little
William Miller‐Little
HWHan Wang
Han Wang
BWBelinda Willard
Belinda Willard
XLXiaoxia Li
Xiaoxia Li
IL‐1β can exit the cytosol as an exosomal cargo following inflammasome activation in intestinal epithelial cells (IECs) in a Gasdermin D (GSDMD)‐dependent manner. The mechanistic connection linking inflammasome activation and the biogenesis of exosomes has so far remained largely elusive. Here, we report the Ras GTPase‐activating‐like protein IQGAP1 functions as an adaptor, bridging GSDMD to the endosomal sorting complexes required for transport (ESCRT) machinery to promote the biogenesis of pro‐IL‐1β‐containing exosomes in response to NLPR3 inflammasome activation. We identified IQGAP1 as a GSDMD‐interacting protein through a non‐biased proteomic analysis. Functional investigation indicated the IQGAP1‐GSDMD interaction is required for LPS and ATP‐induced exosome release. Further analysis revealed that IQGAP1 serves as an adaptor which bridges GSDMD and associated IL‐1β complex to Tsg101, a component of the ESCRT complex, and enables the packaging of GSDMD and IL‐1β into exosomes. Importantly, this process is dependent on an LPS‐induced increase in GTP‐bound CDC42, a small GTPase known to activate IQGAP1. Taken together, this study reveals IQGAP1 as a link between inflammasome activation and GSDMD‐dependent, ESCRT‐mediated exosomal release of IL‐1β.

27 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJingyu Liao
Jingyu Liao
QZQi Zhang
Qi Zhang
YLYun Liao
Yun Liao
BCBei Cai
Bei Cai
JCJie Chen
Jie Chen
LWLanlan Wang
Lanlan Wang
T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) plays an important role in regulating T cells in hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC). However, few researches have reported the association of Tim-3 genetic variants with susceptibility and progression of HBV infection. In this study, we focused on the association of Tim-3 polymorphisms with HBV infection, HBsAg seroclearance and hepatocellular carcinoma. A total of 800 subjects were involved in this study. Four groups were studied here, including HBV, HBsAg seroclearance, HBV-associated HCC and healthy controls. Three single-nucleotide polymorphisms (SNPs) of Tim-3, rs246871, rs25855 and rs31223 were genotyped to analyze the association of Tim-3 polymorphisms with susceptibility and disease progression of HBV infection. Our study found that rs31223 and rs246871 were associated with disease progression of HBV infection, while none of the three SNPs was relevant to HBV susceptibility. The minor allele “C” of rs31223 was found to be associated with an increased probability of HBsAg seroclearance (P = 0.033) and genotype “CC” of rs246871 to be associated with an increased probability of HBV-associated HCC (P = 0.007). In accordance, haplotypic analysis of the three polymorphisms also showed that the haplotype block CGC* and TGC* were significantly associated with HBsAg seroclearance (P<0.05) while haplotype block CAT*, CGT*, TAC* and TGT* were significantly associated with HBV-associated HCC (all P<0.05). Genetic variants of Tim-3 have an important impact on disease progression of HBV infection. With specific Tim-3 polymorphisms, patients infected with HBV could be potential candidates of HCC and HBsAg seroclearance.

8 September 2026 in Advanced Science
Verified
Journal Article
Open access
LYLin Yan
Lin Yan
EZErdi Zhang
Erdi Zhang
YMYuwen Ma
Yuwen Ma
ZMZirui Meng
Zirui Meng
SLSisi Li
Sisi Li
MWMinjin Wang
Minjin Wang
Anti‐ N‐methyl‐D‐aspartate receptor encephalitis (NMDAR‐E) is a prevalent autoimmune neurological disorder, yet T cell‐driven immunopathology and its contributions to therapeutic resistance and fulminant neuroinflammation remain poorly defined. Integrative single‐cell multi‐omic profiling, combining single‐cell RNA sequencing, single‐cell T cell receptor (TCR) sequencing, and cellular indexing of transcriptomes and epitopes by sequencing, is applied to systematically map peripheral and cerebrospinal fluid (CSF) immune landscapes in treatment‐naïve NMDAR‐E patients, with orthogonal validation conducted across independent cohorts via multiparameter flow cytometry and ex vivo NR1 peptide stimulation. Clonally expanded CX3CR1‐expressing CD4 + and CD8 + T cells are identified as a core disease‐associated effector population, characterized by high predicted affinity for the pathogenic GluN1 N368/G369 epitope, robust proinflammatory and cytotoxic transcriptional programs, and enhanced intercellular crosstalk with activated B cells through major histocompatibility complex (MHC), CD99, and macrophage migration inhibitory factor signaling axes. Preferentially enriched in patient CSF, these cells produce elevated interferon‐γ (IFN‐γ) and tumor necrosis factor‐α (TNF‐α) upon antigen‐specific stimulation, collectively highlighting a disease‐associated inflammatory T cell state linked to peripheral immune activation and CNS immune remodeling, with potential translational relevance for future biomarker and therapeutic investigation.